Nucleic Acid for the Treatment of Cancer: Genetic Vaccines and DNA Adjuvants

E-ISSN： 1873-4286|7|16|1641-1667

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.16, 2001-11, pp. : 1641-1667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhanced Efficacy of DNA Vaccines Against an Intracellular Bacterial Pathogen by Genetic Adjuvants

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 2, 2003-04 ,pp. : 99-107

Bentham Science Publishers

Access to resources Recommend Favorite

Locked Nucleic Acid Holds Promise in the Treatment of Cancer

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1138-1142

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccines adjuvants

By Newman M.J.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 3, 2000-03 ,pp. : 279-314

Informa Healthcare

Access to resources Recommend Favorite

DNA vaccines for cancer therapy

By Horton H.M. Parker S.E. Wloch M.K. Norman J.A.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2017-2026

Informa Healthcare

Access to resources Recommend Favorite

Plasmids Encoding Protein Aggregation Domains Act As Molecular Adjuvants for DNA Vaccines

Current Gene Therapy, Vol. 14, Iss. 3, 2014-01 ,pp. : 161-169

Bentham Science Publishers

Access to resources Recommend Favorite